Does daptomycin still have a part to play in the treatment of Enterococcus faecium bacteremia in the intensive care unit?

This publication has 15 references indexed in Scilit:

• Optimal vancomycin AUC24/MIC ratio for predicting clinical outcomes in patients with glycopeptide-susceptible Enterococcus faecium bacteremia
  European Journal of Clinical Microbiology & Infectious Diseases, 2026
• Pharmacokinetic/pharmacodynamic analysis of vancomycin in patients withEnterococcus faeciumbacteraemia: a retrospective cohort study
  European Journal of Hospital Pharmacy, 2023
• The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection
  Journal of Infection and Public Health, 2022
• Association of vancomycin trough concentration on the treatment outcome of patients with bacteremia caused by Enterococcus species
  BMC Infectious Diseases, 2021
• Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature
  Drug Resistance Updates, 2018
• Pharmacokinetics of Daptomycin in Critically Ill Pediatric Patients
  Antimicrobial Agents and Chemotherapy, 2018
• Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis
  Journal of Antimicrobial Chemotherapy, 2017
• β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium
  Journal of Antimicrobial Chemotherapy, 2015
• Emergence of Resistance to Daptomycin during Treatment of Vancomycin-Resistant Enterococcus faecalis Infection
  Clinical Infectious Diseases, 2005
• Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin Therapy
  Antimicrobial Agents and Chemotherapy, 2005